choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Coartem

Coartem Newsletter
  • Switzerland Greenlights New Malaria Medication for Infants 16 Jul 2025 14:42 GMT

    … s drug authority has granted approval for the first malaria medication … populations." The treatment—marketed as Coartem Baby, and known … malaria in babies and toddlers was managed using versions of the drug … to speed up access. Malaria continues to pose a …

  • Switzerland Greenlights New Malaria Medication for Infants 16 Jul 2025 12:54 GMT

    … s drug authority has granted approval for the first malaria medication … populations." The treatment—marketed as Coartem Baby, and known … malaria in babies and toddlers was managed using versions of the drug … to speed up access. Malaria continues to pose a …

  • First malaria treatment approved for babies 16 Jul 2025 06:40 GMT

    … been a safe approved treatment for infants less than … , risking overdose or under‑treatment. As of early this … in conjunction with Novartis and the Medicines for Malaria Venture. The formulation … days. Ghana has already approved Coartem Baby, and a more …

  • Kenya takes part in trials of first malaria treatment for newborns 15 Jul 2025 10:03 GMT

    … Medicines for Malaria Venture (MMV) in collaboration with Novartis, Coartem … Currently, no authorised malaria treatments exist for babies … Coartem Baby is groundbreaking. It is safe and effective in treating malaria … drug that can be used to treat children …

  • Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits 13 Jul 2025 18:50 GMT

    … —UroGen Pharma’s Zusduri became the first FDA-approved treatment for recurrent … authorization. —A new formulation of Novartis malaria drug Coartem won regulatory approval in Switzerland … them. Both are injectable medicines that inhibit a protein called …

  • World : Swiss Authority Approves First Drug To Treat Infants Sick With Malaria 09 Jul 2025 10:31 GMT

    … the first approval for a malaria medicine designed for small infants, touted … Tuesday for the medicine from Basel-based pharmaceutical company Novartis for treatment of babies … access the needed treatment. The newly approved medication, Coartem Baby, is a …

  • First Malaria Drug approved for Newborns and young infants: Study 11 Jul 2025 06:27 GMT

    Novartis has received approval for Coartem Baby, the world's first malaria treatment specifically … . Approved by Swiss regulators, the drug is expected to gain swift … clinical trials. Developed with the Medicines for Malaria Venture (MMV) and other …

  • Daily briefing: The first malaria treatment for babies wins approval 10 Jul 2025 14:33 GMT

    … 4 min read The first malaria treatment specifically formulated for infants … Africa. The drug, made by Novartis and named Coartem Baby or … Swiss non-profit group Medicines for Malaria Venture. It’s … Research — covers biotechnology, drug discovery and pharma

  • FDA Faces Challenges Amid Regulatory Changes and New Drug Approvals 10 Jul 2025 13:24 GMT

    … Novartis has secured approval in Switzerland for Coartem Baby, the first medication … designed to treat malaria in babies … mandates currently required for new drug approval processes. Makary indicated …

  • Swissmedic approves Novartis' Coartem Baby to treat malaria in newborns and young infants 10 Jul 2025 05:46 GMT

    Novartis announced Coartem (artemether-lumefantrine) Baby has been … in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly … the potential to combat rising drug resistance, one of which is …

Satisfied with the content?

Continue to create your account.